Massachusetts Contract Manufacturer Slammed for Violations at Two Sites

Drug Industry Daily
A A
The FDA issued a warning letter to Pharmasol over violations at two of its drug manufacturing facilities, including problems with quality oversight and leaky stability samples.

To View This Article:

Login

Subscribe To Drug Industry Daily